Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries

AIDS, Supplement

Volumn 19, Issue 2, 2005, Pages

  McDougal, J Steven ^a,d   Pilcher, Christopher D ^b   Parekh, Bharat S ^a   Gershy Damet, Guy ^c   Branson, Bernard M ^a   Marsh, Kimberly ^a   Wiktor, Stefan Z ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WHO Regional Office for Africa   (Zimbabwe)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute HIV 1 infection; HIV 1 diagnostics; HIV 1 incidence; HIV 1 surveillance; Tests for recent HIV 1 infection

Indexed keywords

CALIBRATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; VALIDATION PROCESS; ASSAY; DIAGNOSTIC TEST; HIV EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MORBIDITY; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; QUALITY CONTROL; RESOURCE ALLOCATION; VIROLOGY;

EID: 23044447788     PISSN: 13502840     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000172874.90133.7a     Document Type: Review

References (35)

1. Stoneburner RL, Low-Beer D, Tembo GS, Mertins TE, Asiimwe-Okiror G. Human immunodeficiency virus infection dynamics in east Africa deduced from surveillance data. Am J Epidemiol 1996; 144:682-695.
2. Brookmeyer R, Gail MH. AIDS epidemiology: a quantitative approach. New York: Oxford University Press; 1994.
3. Williams B, Gouws E, Wilkinson D, Karim SA. Estimating HIV incidence rates from age prevalence data in epidemic situations. Stat in Med 2001; 20:2003-2016.
4. Saidel T, Sokal D, Rice J, Buzingo T, Hassig T. Validation of a method to estimate age-specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data. Am J Epidemiol 1996; 144:214-223.
5. Wilkinson D, Karim SA, Williams B, Gouws E. High HIV incidence and prevalence among young women in rural South Africa: developing a cohort for intervention trials. J Acquir Immune Defic Syndr 2000; 23:405-409.
6. Gregson S, Donnelly CA, Parker CG, Anderson RM. Demographic approaches to the estimation of incidence of HIV-1 infection among adults from age-specific prevalence data in stable endemic conditions. AIDS 1996; 10:1689-1697.
7. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141:166-172.
8. Cleghorn FR, Jack N, Murphy JR, Edwards J, Mahabir B, Paul R, et al. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am J Epidemiol 1998; 147:834-839.
9. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus incidence rates. Am J Epidemiol 1995; 142:709-713.
10. Rollin NC, Dedicoat M, Danaviah S, Page T, Bishop K, Kleinschmidt I, et al. Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet 2002; 360:389-390.
11. Quinn TC, Brookmeyer R, Kline R, Shepherd M, Paranjape R, Mehendale S, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14:2751-2757.
12. Pilcher CD, McPherson JT, Leone PA, Smurzynski M, Owen-O'Dowd J, Peace-Brewer AL, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002; 288:216-221.
13. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-48.
14. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307.
15. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 2002; 40:4015-4020.
16. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001; 17:137-146.
17. McDougal JS, Kennedy MS, Nicholson JKA, Spira TJ, Jaffe HW, Kaplan JE, et al. Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency and disease progression. J Clin Invest 1987; 80:316-324.
18. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879.
19. Beyrer C, Brookmeyer R, Natpratan C, Kunawararak P, Niraroot V, Palapunya P, et al. Measuring HIV-1 incidence in northern Thailand: prospective cohort results and estimates based on early diagnostic tests. J Acquir Immune Defic Syndr 1996; 12:495-499.
20. Calzavara L, Burchell AN, Major C, Remis RS, Corey L, Myers T, et al. and Polaris Study Team. Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS 2002; 16:1655-1661.
21. Hu DJ, Vanichseni S, Mock PA, Young NL, Dobbs T, Byers R, et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED immunoassay. AIDS Res Hum Retroviruses 2003; 19:727-730.
22. Gouws E, Williams BG, Sheppard HW, Enge B, Karim SA. High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr 2002; 29:531-535.
23. Parekh BS, Hu DJ, Vanichseni S, Satten GA, Candal D, Young NL, et al. Evaluation of a sensitive/less sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Res Hum Retroviruses 2001; 17:453-458.
24. Constantine JT, Sill AM, Jack N, Kreisel K, Edwards J, Cafarella T, et al. Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J Acquir Immune Defic Syndr 2003; 32:94-103.
25. Kothe D, Byers R, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003; 33:625-634.
26. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr 2003; 33:349-355.
27. Murphy D, Charlett A, Osner N, Gill ON, Parry JV. Reconciling HIV incidence results from two assays employed in the serological testing algorithm for recent HIV seroconversion (STARHS). J Virol Methods 2003; 113:79-86.
28. McFarland W, Busch MP, Kellogg TA, Rawal BD, Satten GA, Katz MH, et al. Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco. J Acquir Immune Defic Syndr 1999; 22:484-490.
29. Dukers NH, Spaargaren J, Geskus RB, Beijnen J, Coutinho RA, Fennema HS. HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections. AIDS 2002; 16:19-24.
30. McFarland W, Kellogg TA, Louie B, Murrill C, Katz MH. Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998. J Acquir Immune Defic Syndr 2000; 23:426-429.
31. Weinstock H, Dale M, Gwinn M, Satten GA, Kothe D, Mei JV, et al. HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr 2002; 29:478-483.
32. Alves K, Shafer KP, Caseiro M, Rutherford G, Falcao ME, Sucupira MC, et al. Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999. J Acquir Immune Defic Syndr 2003; 32:551-559.
33. Machado DM, Delwart EL, Diaz RS, de Oliveira CF, Alves K, Rawal BD, et al. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS 2002; 16:113-119.
34. Turchi MD, Diaz RS, Martelli CMT, Sabino EC, da Silva WP, Filho OF, et al. Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 2002; 30:527-532.
35. Murphy G, Charlett A, Jordan LF, Osner N, Gill ON, Parry JV. HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy. AIDS 2004; 18:265-272.